The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia
Phase 3
Completed
- Conditions
- Type 2 DiabetesHyperlipidemia
- Registration Number
- NCT01360567
- Lead Sponsor
- Taipei City Hospital
- Brief Summary
The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.
- Detailed Description
Percent change Homa insulin resistance, cholesterol and triglycerol.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
- Age 20--69 years old
- Type 2 diabetes for > one year
- TG >= 150 mg/dl or LDL >= 100 mg/dl
Exclusion Criteria
- GPT > 80 mg/dl
- Creatinine > 1.8 mg/dl
- Pregnancy
- AMI
- Stroke
- Operational or any not suitable patients diagnosis physician in charge
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percent change of HOMA insulin resistance and TG 16 weeks
- Secondary Outcome Measures
Name Time Method Percent change of HbA1C and Cholesterol 16 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie green tea extract's effects on HOMA-IR in type 2 diabetes patients?
How does green tea extract compare to statins in managing hyperlipidemia and glycemic control in T2DM?
Which biomarkers correlate with triglyceride reduction in NCT01360567 green tea extract trials?
What adverse events are associated with long-term green tea extract supplementation in diabetic populations?
Are there synergistic effects when combining green tea extract with metformin for T2DM and hyperlipidemia?
Trial Locations
- Locations (2)
Chung-Hua Hsu
🇨🇳Taipei, Taiwan
Taipei City Hospital
🇨🇳Taipei, Taiwan
Chung-Hua Hsu🇨🇳Taipei, Taiwan